Teva Pharmaceutical Industries
TEVA
#541
Rank
HK$352.75 B
Marketcap
HK$302.32
Share price
-8.74%
Change (1 day)
58.87%
Change (1 year)

EPS for Teva Pharmaceutical Industries (TEVA)

EPS in 2026 (TTM): HK$3.50

According to Teva Pharmaceutical Industries's latest financial reports the company's current EPS (TTM) is HK$3.53. In 2024 the company made an earnings per share (EPS) of -HK$11.37 a decrease over its 2023 EPS that were of -HK$3.69.

EPS history for Teva Pharmaceutical Industries from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$3.50
2024-HK$11.37208.51%
2023-HK$3.69-77.83%
2022-HK$16.63-657.89%
2021HK$2.98
2019-HK$7.22-60.34%
2018-HK$18.20-85.73%
2017-HK$127.55-23328.57%
2016HK$0.55-96.2%
2015HK$14.43-48.6%
2014HK$28.08138.67%
2013HK$11.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.18 1,066.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57 57.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.54 340.12%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$7.79 120.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$55.85 1,482.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$22.57 539.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
HK$2.84-19.54%๐Ÿ‡ฎ๐Ÿ‡ณ India